Autolus Therapeutics | 8-K: Current report
Apr 1 19:11
Autolus Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Mar 29 10:35
Autolus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Renata Kellnerova(5.5%),PPF GROUP N.V.(5.5%), etc.
Mar 26 04:14
Autolus Therapeutics | 10-K: Annual report
Mar 22 10:17
Autolus Therapeutics | 8-K: Current report
Mar 22 04:27
Autolus Therapeutics | 8-K/A: Current report (Amendment)
Mar 16 04:29
Autolus Therapeutics | 8-K: Current report
Mar 15 00:35
Autolus Therapeutics | D: Filing D
Feb 24 06:35
Autolus Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-BioNTech SE(12.5%)
Feb 22 06:07
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Feb 15 06:52
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(2.21%),Steven Boyd(2.21%)
Feb 15 03:47
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(6.82%),Deep Track Biotechnology Master Fund, Ltd.(6.82%), etc.
Feb 14 21:41
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Feb 14 07:46
Autolus Therapeutics | 8-K: Current report
Feb 14 05:16
Autolus Therapeutics | 424B5: Prospectus
Feb 10 06:22
Autolus Therapeutics | 8-K: Current report
Feb 9 05:23
Autolus Therapeutics | 8-K: Current report
Feb 8 19:10
Autolus Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 8 19:05
Autolus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Tetragon Financial Group Limited(4.6%),Tetragon Financial Management L.P.(4.6%), etc.
Feb 1 05:13
Autolus Therapeutics | 8-K: Current report
Jan 27 02:04
No Data
No Data